YUNG SHIN PHARM. IND. CO., LTD.

🇹🇼Taiwan

Country: 🇹🇼Taiwan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Completed

Conditions: Nonsmall Cell Lung Cancer
Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Nolbaxol
Drug: Taxotere
Drug: cisplatin

First Posted Date: 2016-11-23

Last Posted Date: 2016-11-23

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 40

Registration Number: NCT02972216

Pharmacokinetics of Two Different Formulation of Voriconazole

Phase 4

Completed

Conditions: Fungus Infection

Interventions: Drug: VFEND FC Tablets 200mg (Voriconazole)
Drug: Vaway FC Tablets 200mg (Voriconazole)

First Posted Date: 2016-09-23

Last Posted Date: 2016-09-23

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 29

Registration Number: NCT02912156

Pharmacokinetics of Two Formulations of Entecavir

Phase 4

Completed

Conditions: Hepatitis B

Interventions: Drug: (Baraclude 0.5mg Tablets
Drug: Entigin Film Coated Tablet 0.5mg

First Posted Date: 2016-08-01

Last Posted Date: 2016-08-01

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 39

Registration Number: NCT02850848

Bioequivalence of Two Formulations of Esomeprazole

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Esomelone
Drug: Nexium

First Posted Date: 2015-09-07

Last Posted Date: 2015-09-07

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 14

Registration Number: NCT02543606

Locations: 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan

Bioequivalence of Two Formulations of Meropenem Intravenous Injection

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Meropem
Drug: Mepem

First Posted Date: 2015-01-26

Last Posted Date: 2015-01-26

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 14

Registration Number: NCT02344563

Bioequivalence of Two Formulations of Acyclovir

Phase 4

Completed

Conditions: Healthy

Interventions: Drug: Acyclovir

First Posted Date: 2014-10-03

Last Posted Date: 2014-10-03

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 14

Registration Number: NCT02255734

Locations: 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan

A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis

Phase 2

Completed

Conditions: Herpes Labialis

Interventions: Drug: placebo
Drug: VDO gel

First Posted Date: 2014-08-04

Last Posted Date: 2016-04-15

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 40

Registration Number: NCT02207881

Locations: 🇨🇳
Changhua Christian Hospital, Changhua, Taiwan

A Study of Vacyless® Versus Valtrex® in Patients With Herpes Zoster

Phase 4

Completed

Conditions: Herpes Zoster

Interventions: Drug: valacyclovir hydrocholoride

First Posted Date: 2014-06-02

Last Posted Date: 2014-06-02

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 25

Registration Number: NCT02152800

Locations: 🇨🇳
Taichung Veterans General Hospital, Taichung, Taiwan

A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women

Phase 2

Completed

Conditions: PMS
Hot Flashes

Interventions: Drug: I placebo capsule
Drug: II RDC 0.3mg capsule
Drug: III RDC 0.6mg capsule

First Posted Date: 2014-04-01

Last Posted Date: 2022-02-14

Lead Sponsor: Yung Shin Pharm. Ind. Co., Ltd.

Target Recruit Count: 58

Registration Number: NCT02100540

Locations: 🇨🇳
Changhua Christian Hospital, Changhua, Taiwan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy